GlassScriptPhysician profile
Edgar X Correa
NPI 1194708263
$6,049.98
in general payments reported to CMS, 2019-2025
14 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $30.49 · 2021: $3,360 · 2022: $1,294 · 2023: $182 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $456 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $456.02 |
| Food and Beverage | $196.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,485.08 | 2019-2021 | |
| Southtech Orthopedics | $1,616.40 | 2021-2022 | |
| Tricoast Surgical Solutions LLC | $495.76 | 2022-2025 | |
| Stryker Corporation | $134.44 | 2022-2023 | Prophecy, Easyfuse, Augment Injectable |
| Smith+Nephew, INC. | $72.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $52.65 | 2019 | |
| Nevro Corp. | $37.52 | 2023 | Senza |
| Pacira Therapeutics, INC. | $34.80 | 2019-2020 | |
| Ethicon US, LLC | $28.00 | 2019 | |
| Fidia Pharma USA INC. | $25.81 | 2023 | Triluron, Hymovis |
| Paragon 28, INC. | $23.04 | 2023 | Gorilla |
| Bioventus LLC | $15.32 | 2022 | |
| Depuy Synthes Sales INC. | $14.47 | 2025 | Monovisc, Orthovisc |
| Endo Pharmaceuticals INC. | $13.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.